~~<i id='720D258DF3'><strike id='720D258DF3'><tt id='720D258DF3'><pre id='720D258DF3'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

author：entertainment 2025-10-02 21:05:49 - browse：55545

Elite athletes really are different from you and me. Or, at least their gut microbes are.

Scientists who analyzed stool samples of 15 runners a week before and after they competed in the 2015 Boston Marathon found unusually high levels of one particular microbe compared to 10 non-athletes. Levels of the microbe in question, Veillonella, spiked after an intense workout and bloomed even more after the marathon.

That was a lightbulb moment for the scientists because the bacterium is known for breaking down and eating lactate, a metabolite even ordinary runners equate with fatigue.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Dramatically reducing cancer deaths requires the PASTEUR Act

entertainment

leisure time

explore

Wikipedia

AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

WSS

Nearly two

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Attacks on the drug industry will lead to fewer breakthroughs

Long Covid research funding gets a major boost from NIH

Readout Newsletter: Amylyx, Aurinia, and IQVIA

ProMED, early warning system on disease outbreaks, in peril

explore

explore

entertainment

Bright Health sells Medicare Advantage business to Molina

Latigo launches with $135 million for Vertex

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Peter Hotez and the public health issue of online harassment

Congress considering partial increase for doctor pay in Medicare

Hepatitis C has a cure — but many Americans still lack access to it

STAT Boddities: What happens to the brain when we get scared?

Anesthesiologist group: stop taking Ozempic before surgery

Humana, CVS hope to turn members into patients at clinics

entertainment

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Latigo launches with $135 million for Vertex

Eli Lilly reports tirzepatide MASH success during Q4 earnings

The drug industry sees a key ally in the Senate prevail

Abbott's new heart device gets FDA advisory panel nod

leisure time

leisure time

explore

Wikipedia